Education
About Us
Working with TipRanks
Follow Us
BioCardia Inc (BCDA)
NASDAQ:BCDA
Earnings Data
Report Date
Apr 01, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.17Last Year’s EPS
-0.59Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted significant progress in clinical trials, regulatory advancements, and partnerships, suggesting a strong potential for future growth. However, increased expenses and a reported net loss present ongoing financial challenges.Company Guidance
Positive Preliminary Clinical Consultation in Japan
BioCardia announced a positive preliminary clinical consultation with Japan's pharmaceutical and medical device agency (PMDA) for the CardiAmp system, indicating potential for market entry in Japan.
Advancement of CardiAmp Heart Failure II Trial
The CardiAmp Heart Failure II confirmatory Phase III trial is accelerating with four centers actively enrolling and showing promising results in patients with elevated NT proBNP.
CardiAmp Cell Therapy Receives FDA Breakthrough Designation
The CardiAmp system has received FDA breakthrough designation based on clinical results, highlighting its potential to treat ischemic heart failure patients effectively.
Partnership for Heart 3D Fusion Imaging
BioCardia announced a partnership with CAR TECH for developing and commercializing Heart 3D Fusion Imaging, showing promising results in animal studies.
Non-Dilutive Funding Expectations
BioCardia expects non-dilutive funding to complete the Phase I-II trial for its BCDA-03 program in 2026, with promising federal grant funding discussions.
BCDA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BCDA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 12, 2025 | $1.30 | $1.26 | -3.08% |
Aug 11, 2025 | $1.79 | $1.68 | -6.15% |
May 14, 2025 | $2.77 | $2.32 | -16.25% |
Mar 26, 2025 | $2.55 | $2.68 | +5.10% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does BioCardia Inc (BCDA) report earnings?
BioCardia Inc (BCDA) is schdueled to report earning on Apr 01, 2026, After Close (Confirmed).
What is BioCardia Inc (BCDA) earnings time?
BioCardia Inc (BCDA) earnings time is at Apr 01, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BCDA EPS forecast?
BCDA EPS forecast for the fiscal quarter 2025 (Q4) is -0.17.